PRIME SUBGROUP ANALYSIS DEMONSTRATES 22% REDUCTION IN NICU ADMISSIONS IN FIRST-TIME PREGNANCIES USING PreTRM® Test-GUIDED CARE

PRIME SUBGROUP ANALYSIS DEMONSTRATES 22% REDUCTION IN NICU ADMISSIONS IN FIRST-TIME PREGNANCIES USING PreTRM® Test-GUIDED CARE

- Study Highlights Screening Efficiency and Potential Cost Savings in a Large Underserved Population -

Analysis shows 22% cut in NICU admissions in first-time pregnancies with Sera’s PreTRM - BioTuesdays

Sera Prognostics (NASDAQ: SERA) has announced publication of a new subgroup analysis from the PRIME trial demonstrating that its PreTRM Test-guided care in first-time pregnancies significantly improved neonatal outcomes, including a 22% reduction in neonatal intensive care unit (NICU) admissions. The findings were published in The Journal of Maternal-Fetal & Neonatal Medicine and highlight the clinical value of early risk stratification using th…